Showing results (71-80 of 147) with videos related to
Sort By:
Pageof 15
Brain : a Journal of Neurology|August 28, 2001
Short-term brain volume change in relapsing-remitting multiple sclerosis: effect of glatiramer acetate and implicationsM Rovaris, G Comi, M A Rocca, et al.Neurology|September 12, 2001
Determinants of overall quality of life in secondary progressive MS: a longitudinal studyP O'Connor, L Lee, P T Ng, et al.Infection and Immunity|January 1, 1982
Differentiation of mumps virus strains with monoclonal antibody to the HN glycoproteinA C Server, D C Merz, M N Waxham, et al.The Journal of General Virology|July 1, 1983
Biosynthesis of mumps virus F glycoprotein: non-fusing strains efficiently cleave the F glycoprotein precursorD C Merz, A C Server, M N Waxham, et al.Acta Neurologica Scandinavica|December 15, 2004
Neurologic consequence of delaying glatiramer acetate therapy for multiple sclerosis: 8-year dataK P Johnson, C C Ford, R P Lisak, et al.Virology|August 1, 1987
Cloning and sequencing of the mumps virus fusion protein geneM N Waxham, A C Server, H M Goodman, et al.Journal of Medical Virology|June 1, 1986
Antibody response to the rubella virus structural proteins in infants with the congenital rubella syndromeA de Mazancourt, M N Waxham, J C Nicolas, et al.Archives of Neurology|May 1, 1975
Acquired toxoplasmosis. A neglected cause of treatable nervous system diseaseJ J Townsend, J S Wolinsky, J R Baringer, et al.Journal of Virology|February 1, 1993
Immunodominant T-cell epitopes of rubella virus structural proteins defined by synthetic peptidesM McCarthy, A Lovett, R H Kerman, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|October 28, 2008
3D MPRAGE improves classification of cortical lesions in multiple sclerosisF Nelson, A Poonawalla, P Hou, et al.Pageof 15